Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pathologic Complete Response”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07400094
What this trial is testing

Neoadjuvant Chemoimmunotherapy (Camrelizumab + Paclitaxel + Carboplatin) for Resectable HNSCC

Who this might be right for
Squamous Cell Carcinoma of Head and NeckLaryngeal NeoplasmsOral Cavity Neoplasm
National Medical Research Radiological Centre of the Ministry of Health of Russia 50
Testing effectiveness (Phase 2)UnknownNCT04006041
What this trial is testing

Combination of Toripalimab and Neoadjuvant Chemoradiotherapy in Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma by AJCC V8 StageResectable Esophageal Cancer
Jianhua Fu 44
Large-scale testing (Phase 3)Study completedNCT01815853
What this trial is testing

Neoadjuvant Chemoradiotherapy vs. Chemotherapy Followed by Radical Gastrectomy and Adjuvant Chemotherapy for Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Sun Yat-sen University 620
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06851169
What this trial is testing

This is a Two-cohort, Exploratory Clinical Study Assessing the Activity of Benmelstobart Alone or Combined with Anlotinib Administered Prior to Surgery in Terms of Pathological Complete Response

Who this might be right for
Non Small Cell Lung Cancer
Tang-Du Hospital 58
Not applicableActive Not RecruitingNCT03876951
What this trial is testing

Evaluation of the Accuracy of Percutaneous Biopsy by Vacuum-assisted Biopsy (VAB) to Assess Pathological Complete Response in Patients With Clinical and Radiological Complete Response After Neoadjuvant Chemotherapy (NeoVAB)

Who this might be right for
Vacuum-assisted Biopsy
Centre Georges Francois Leclerc 67
Testing effectiveness (Phase 2)Looking for participantsNCT05563766
What this trial is testing

A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer

Who this might be right for
Esophageal AdenocarcinomaEsophageal Squamous Cell CarcinomaGastroesophageal Junction Carcinoma
VA Office of Research and Development 78
Testing effectiveness (Phase 2)WithdrawnNCT00408967
What this trial is testing

Determine if Either of 2 Doses of Study Drug Given With a Low-dose of Cyclophosphamide After a Complete or Partial Response to a Platinum-based Second-line Therapy in Women With Recurrent Ovarian Carcinoma Results in a Longer Time to Progression When Compared to the First Time to Progression.

Who this might be right for
Ovarian Cancer
EMD Serono
Testing effectiveness (Phase 2)UnknownNCT01566799
What this trial is testing

Metformin Plus Neoadjuvant Chemotherapy in Breast Cancer

Who this might be right for
Locally Advanced Malignant Neoplasm
Instituto Nacional de Cancerologia de Mexico 60
Not applicableStudy completedNCT05931042
What this trial is testing

Neoadjuvant Therapy With Trastuzumab and Chemotherapy and the Resultant Pathologic Complete Response Observed in HER2 Positive Breast Cancer;a Systematic Review

Who this might be right for
HER2+ Breast Cancer
Rawalpindi Medical College 1,209
Not applicableNot Yet RecruitingNCT07404228
What this trial is testing

Multidimensional Study Designed to Develop a Methodological Framework Based on MRI Data to Predict Pathological Complete Response (pCR) in Patients With Locally Advanced Rectal Cancer After Neoadjuvant Treatment

Who this might be right for
Rectal CancerChemoradiotherapyMri
Institut du Cancer de Montpellier - Val d'Aurelle 115
Early research (Phase 1)Study completedNCT02134600
What this trial is testing

OmegaChild - Omega-3 Supplementation to Children Previously Treated for Cancer

Who this might be right for
Pediatric Cancer
Per Kogner 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT01424982
What this trial is testing

Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic Leukemia

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Lymphoblastic LeukemiaAdult Acute Lymphoblastic Leukemia in Complete Remission+4 more
M.D. Anderson Cancer Center 88
Large-scale testing (Phase 3)UnknownNCT01088022
What this trial is testing

Aprepitant for Prevention of Acute and Delayed Nausea and Vomiting in Patients Receiving a High-emetogenic Dose of Cyclophosphamide for Peripheral Blood Stem Cells Harvesting

Who this might be right for
NauseaVomiting
Azienda Ospedaliera di Perugia 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07702851
What this trial is testing

Polatuzumab Vedotin and Glofitamab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma Within 12 Months After R-CHOP

Who this might be right for
Diffuse Large B-cell Lymphoma
Yonsei University 47
Large-scale testing (Phase 3)Ended earlyNCT01095445
What this trial is testing

EXtended Therapy in Hepatitis C Genotype 3 Infected Patients

Who this might be right for
Chronic Hepatitis C
University Health Network, Toronto 2
Not applicableUnknownNCT05750693
What this trial is testing

PIK3CA in HER2+ BC and pCR Trial

Who this might be right for
HER2-positive Breast Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 58
Testing effectiveness (Phase 2)Looking for participantsNCT07007052
What this trial is testing

Phase II Study Evaluating the Efficacy and Safety of the Combination of Tagraxofusp and Venetoclax in Treatment-naive Blastic Plasmacytoid Dendritic Cell Neoplasm Patients

Who this might be right for
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
French Innovative Leukemia Organisation 33
Testing effectiveness (Phase 2)Study completedNCT00363649
What this trial is testing

Interferon and GM-CSF Compared With Imatinib Mesylate and Vaccine Therapy in Patients With Chronic Phase CML on a TKI

Who this might be right for
Leukemia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 36
Not applicableLooking for participantsNCT05866458
What this trial is testing

Radiation OmisSion in PAtients With CLinically Node Negative Breast Cancer Undergoing Lumpectomy

Who this might be right for
Breast Cancer
Ontario Clinical Oncology Group (OCOG) 352
Not applicableLooking for participantsNCT07088354
What this trial is testing

Deep Learning Model Predicts Pathological Complete Response of Esophageal Squamous Cell Carcinoma Following Neoadjuvant Immunochemotherapy

Who this might be right for
Esophageal Squamous Cell CarcinomaNeoadjuvant ImmunochemotherapyPathological Complete Response+1 more
Tongji Hospital 300
Next Page